Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy

Author:

Jia Xiaobo1,Zhang Yihua2,Zou Yu2,Wang Yao1,Niu Dechao1,He Qianjun3,Huang Zhangjian2,Zhu Weihong4,Tian He4,Shi Jianlin1,Li Yongsheng1ORCID

Affiliation:

1. Lab of Low-Dimensional Materials Chemistry; Key Laboratory for Ultrafine Materials of Ministry of Education; School of Materials Science and Engineering; East China University of Science and Technology; Shanghai 200237 P. R. China

2. State Key Laboratory of Natural Medicines; Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases; China Pharmaceutical University; Nanjing 210009 P. R. China

3. Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging; School of Biomedical Engineering; Health Science Center; Shenzhen University; Shenzhen 518060 China

4. Shanghai Key Laboratory of Functional Materials Chemistry; Key Laboratory for Advanced Materials and Institute of Fine Chemicals; East China University of Science & Technology; Shanghai 200237 China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Program of Shanghai Academic/Technology Research Leader

Basic Research Program of Shanghai

Shanghai Rising-Star Program

111 project

Fundamental Research Funds for Central Universities

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3